Canine pancreatitis injectable lands U.S. distributionMay 18, 2023Panoquell-CA1’s active ingredient, fuzapladib sodium, has been approved for canine use in Japan since 2018.
SPONSORED CONTENTIs your parasite protocol missing something?Adding Hill’s GI nutrition to your parasite protocol supports GI healing for more complete diarrhea management than medication alone. + Learn More
Clinical trial aims to treat canine pancreatitisFebruary 6, 2020ISK and AlcheraBio are seeking clinics to serve as clinical investigator sites to explore treatment options for patients diagnosed with acute canine pancreatitis (ACP).
